Profile
Henrik Damkjær Simonsen currently works at Iconovo AB, as Chief Financial Officer from 2023.
Mr. Simonsen also formerly worked at Skandinaviska Enskilda Banken AB (Broker Denmark), as Analyst from 2004 to 2011, Nuevolution AB, as Chief Financial Officer, and SAGA Diagnostics AB, as Chief Financial officer.
Mr. Simonsen received his graduate degree from the University of Copenhagen.
Henrik Simonsen active positions
| Companies | Position | Start |
|---|---|---|
| ICONOVO AB | Director of Finance/CFO | 31/03/2023 |
Former positions of Henrik Simonsen
| Companies | Position | End |
|---|---|---|
Skandinaviska Enskilda Banken AB (Broker Denmark)
Skandinaviska Enskilda Banken AB (Broker Denmark) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31/12/2010 |
SAGA Diagnostics AB
SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance | Director of Finance/CFO | - |
| NUEVOLUTION AB (PUBL) | Director of Finance/CFO | - |
Training of Henrik Simonsen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skandinaviska Enskilda Banken AB (Broker Denmark)
Skandinaviska Enskilda Banken AB (Broker Denmark) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Nuevolution AB
Nuevolution AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for treatment of oncology and chronic inflammatory diseases | Health Technology |
Iconovo AB
Iconovo AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that manufactures and wholesales powder-based inhalation drugs and devices | Health Technology |
SAGA Diagnostics AB
SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance | Health Technology |
- Stock Market
- Insiders
- Henrik Simonsen
















